Accumulating evidence has demonstrated that the expression of ETNPPL occurs in numerous malignancies, such as primary glioblastoma, colorectal cancer, gastric cancer, pancreatic cancer, and HCC (González-García et al., 2020; Deng et al., 2020; Ding et al., 2016). This evidence concerns the gene ETNPPL and pancreatic neoplasm.